White Paper
|
By Cheryl Bondurant, Ellyn Ludden, and Harry Benson,
CAI
Learn about three industry survival methods that when applied can ensure generational workforces are blending cohesively: engagement, culture, and communication.
|
|
Article
|
By Petter Moree and Joe Reckamp,
Seeq Corporation
Multivariate analysis, which allows operators to model processes with several signals, can afford manufacturers a holistic, interconnected view of their operations in near real time.
|
|
Article
|
By Tom Stapp and Kelsey Gomez,
CHIRON Recombinant Proteins
Once a company has demonstrated proof of concept, it is critical to consider process elements such as scalability, sourcing raw materials, and GMP adherence.
|
|
e-book
|
Thermo Fisher Scientific
Bioavailability challenges are an inherent part of the drug development process. Review some risky assumptions surrounding bioavailability during development and key considerations for addressing them.
|
|
Article
|
By Ryan Rivers, Shane Mohr, and Lisa DeOerio,
Emergent CDMO
Restricted access barrier system or isolator technologies are an integral component of quality control. Understanding the key elements of each ensures the most informed decision for your product.
|
|
Article
|
By Jennifer Weber, Jerry (Yue) Zhou, Yulong Hong, and Ann Ferrie,
Corning Life Sciences
The Corning Ascent FBR System can ease or eliminate therapy developers’ difficult choices between adherent and suspension cell culture platforms when scaling production.
|
|
Article
|
Pfizer CentreOne
How can pharma companies secure the supply of vital APIs and intermediates and maintain consistent manufacturing costs? These steps minimize supply chain insecurity in a rapidly changing market.
|
|
Article
|
Cytiva
As a translational researcher, you’re paving an uncharted path toward exciting new possibilities in healthcare. Explore five difficulties translational researchers face when developing a new therapy.
|
|
Article
|
By Joe Cintavey,
W.L. Gore & Associates
Explore how to develop a strong packaging system and learn more about why a reliable supply chain is critical for drug substance and drug product transport.
|
|
Case Study
|
Cambrex
The successful transition from initial synthesis of an API to a kilogram-scale route requires expert analysis and design, and a balance of economic, regulatory, and time constraints.
|
|
White Paper
|
By Kayla J. Spivey,
Thermo Fisher Scientific
Here we will discuss the scalable process workflow solutions available from initial R&D investment to clinical testing and commercialization.
|
|
Video
|
Advanced Instruments, Inc.
This virtual presentation of the OsmoTECH XT demonstrates how easy the instrument is to use and explains its key features for osmolality measurement productivity and reliability.
|
|
Virtual Event
|
Sartorius
Learn what process analytical technology is enabling, the efficiencies it's driving, and the role it's playing as early adopters work ever closer to continuous biopharmaceutical manufacturing.
|
|
Webinar
|
Entegris, Inc.
This webinar focuses on how filtration manufacturers optimize materials for performance and integration within single-use systems.
|
|
Article
|
By Kristin Heller, Andrew Moreo, and Jonathan Rush,
Andelyn Biosciences
A CDMO with in-house plasmid manufacturing capabilities can help companies accelerate timelines and ensure material availability, ultimately saving time and money throughout their product life cycle.
|
|